Number of Shares
1.26 Mil
Current Holdings Value*
$3.20 Mil
% of Portfolio
36.88%
Total Estimate Gain
$2.54 Mil
% of Total Estimate Gain
55.00%

Athyrium Capital Management, LP's Puma Biotechnology Inc Holding Summary

As of 2024-09-30, Athyrium Capital Management, LP held 1.26 Mil shares of Puma Biotechnology Inc(PBYI), totaling $3.20 Mil. This investment constitutes 36.88% of their stock portfolio, and Athyrium Capital Management, LP now holds 2.56% of the outstanding Puma Biotechnology Inc(PBYI) stock.

The initial trade took place in 2022Q1. And since then Athyrium Capital Management, LP has made 1 purchases of PBYI, at an average price of $2.58, for a total of 1.79 Mil shares. In addition, there have been 1 sales at an average price of $5.38 for 535,703.00 shares. Based on historical transaction data and PBYI's current price of $3.41, Athyrium Capital Management, LP's estimated gain on his PBYI holdings is $2.54 Mil, reflecting a 55.00% gain to date.

Athyrium Capital Management, LP PBYI ($3.41) Holding Chart

Athyrium Capital Management, LP PBYI ($3.41) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1